ردود أفعال واسعة على حملة “اليوم السابع”.. اللحوم المصنعة أخطر من الخمرة والسجائر.. المعهد القومى للتغذية: تحتوى على مواد مسرطنة وملح البارود.. والأطباء: تزيد إصابة الأطفال بالسكر والسرطان – خبراء ينصحون بمشروب سحرى لإزالة السموم من الجسم يشمل القرفة والزنجبيل والجزر والبنجر والعسل والكيوى والتفاح أثارت حملة «اليوم السابع» للتوعية بمخاطر اللحوم المصنعة ردود أفعال
Merck’s Zinplava Approved to Fend Off Return of Clostridium Difficile Zinplava (bezlotoxumab) has been FDA-approved to reduce the recurrence of Clostridium difficile infection (CDI) in adults who are receiving antibacterial drug treatment for CDI and who are at high risk for CDI recurrence. Zinplava is not an antibacterial and does not treat an active CDI
The FDA has just approved the first automated insulin delivery device for patients 14 years and older with type 1 diabetes (T1D). Medtronic’s MiniMed 670G hybrid closed looped system, often referred to as an artificial pancreas, serves as an automatic glucose monitor and basal insulin dose dispenser. The device adjusts insulin with little or no
RARITAN, N.J., September 21, 2016 – Janssen Pharmaceuticals, Inc. (Janssen) announced today the U.S. Food and Drug Administration (FDA) has approved Invokamet XR – a once-daily, fixed-dose combination therapy of canagliflozin and metformin hydrochloride extended-release (XR)—for first-line use as an adjunct to diet and exercise to improve blood glucose control in adults with type 2
Regardless of whether you are a member of a quality assurance department in the pharmaceutical industry or not, the term quality risk management (QRM) is likely familiar to you. This is because QRM, a systematic process that assesses risk to the quality of a drug product across its lifecycle (quality risk assessment), is also often
Find out what you are taking with the “British Medical Association Concize Guide to the Medicines & Drugs”. Easy to read, it gives you all the vital information you need to know on today’s most common drugs. The book is divided into three parts. The first part is subdivided into sections dealing with each body
Pfizer Inc. has announced that Dr. Ole Isacson, a world-renowned scientist and thought leader in neurology, will become Chief Scientific Officer of the Neuroscience Research Unit and Senior Vice President, effective September 16. Dr. Isacson is a Professor of Neurology at Harvard Medical School, and will continue to serve in an educational role. He is
AstraZeneca is pulling back its application to market ovarian cancer drug cediranib in Europe, marking the end of the line for the drug in combination was chemotherapy. The firm was seeking approval for use of its oral VEGFR inhibitor in combination with platinum-based chemotherapy followed by maintenance monotherapy to treat adult patients with platinum-sensitive relapsed
Gilead Sciences has pulled the plug on a combined Phase II/III clinical study of GS-5745 testing the investigational anti-MMP9 antibody in patients with moderately to severely active ulcerative colitis. The decision follows a planned interim analysis of unblinded efficacy and safety data by the Data Monitoring Committee, after the first 150 patients of a planned
According to FDA and other sources, tobacco use is the single largest preventable cause of disease and death in the United States. Ned MilenkovichAs part of its goal to improve public health and protect future generations from tobacco use risk, the FDA has engaged in rulemaking to extend its jurisdictional authority over all products that
A historic declaration to combat antimicrobial resistance has been signed by 193 countries at a United Nations General Assembly. Each signatory has agreed that drug resistant infections must be tackled as a priority, in light of projections that, by 2050, 10 million people a year will be dying as a result at a cost to
July 5, 2016 — The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years. “The FDA’s approval
Sanofi is taking Merck & Co to court claiming that the firm has infringed 10 patents covering its best-selling insulin glargine products Lantus and Lantus SoloStar. The French drugmaker said it has filed a patent infringement suit against Merck in the US District Court for the District of Delaware, triggered by Merck filing a New
At the signing ceremony of the new research collaboration: Back row from left: Dr. Simone Gatzke, Forschungszentrum Juelich, Raphael Dumain, Dr. Isolde Häuser-Hahn and Dr. habil Guenter Welz from Bayer, Prof. Ulrich Schurr, Juelich, Dr. Samir Bennabi, Bayer. Front row from left: Dr. Adrian Percy, Bayer, Prof. Michelle Watt and Prof. Harald Bolt, Forschungszentrum Juelich.
RIYADH: A significant rise in lifestyle-related diseases and the developments in health care infrastructure will influence the demand for pharmaceuticals in Saudi Arabia that will reach about SR19.5 billion this year in cumulative cost. This will represent a growth of 6 percent in the total procurement of pharmaceuticals in the Kingdom this year compared to
The three primary criteria for a pharmaceutical company to investigate when building a marketing strategy are market size and growth, protection of intellectual property rights and enforcement of said rights. This report provides an insight into these criteria as they relate to the MENA market. Pharmaceuticals market in MENA At close to USD20 billion, the
GlaxoSmithKline Plc’s new chief executive looks a lot like other bosses at large pharmaceutical companies: a graduate of Oxford, white, with worldwide experience managing thousands of employees. There is, though, one big difference: She’s not a man. Emma Walmsley will lead the British drugmaker starting in March, breaking the gender barrier at the world’s top
